Esperion Therapeutics Inc (ESPR)
Investing Cash Flow
$0.00
TTM · Period ending: · USD
ESPR Investing Cash Flow
Latest reported$0.00period ending
Latest reported$0.00period ending
ESPR TTM Cash from Investing (-$2.02M → $0.00)
TTM investing cash flow
High-resolution chart · PNG
ESPR investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| 0 | |
| 189,000 | |
| 0 | |
| -167,000 | |
| -244,000 | |
| -317,000 | |
| -317,000 | |
| -150,000 | |
| 17,427,000 | |
| 42,500,000 | |
| 30,706,000 | |
| 63,706,000 | |
| 51,206,000 | |
| 8,104,000 | |
| -30,586,000 | |
| -63,586,000 | |
| -68,586,000 | |
| -50,484,000 | |
| -12,676,000 | |
| -10,343,000 | |
| -5,233,000 | |
| 21,356,000 | |
| 31,164,000 | |
| 23,518,000 | |
| 45,124,000 | |
| 64,231,000 | |
| 105,667,000 | |
| 151,008,000 | |
| 155,862,000 | |
| 140,449,000 | |
| 150,280,000 | |
| -17,271,000 | |
| -21,738,000 | |
| -35,853,000 | |
| -76,500,000 | |
| 64,093,000 | |
| 56,248,000 | |
| 10,118,000 | |
| 7,711,000 | |
| -42,618,000 | |
| -132,482,000 | |
| -160,068,000 | |
| -204,296,000 | |
| -166,252,000 | |
| -95,299,000 | |
| -36,598,000 | |
| -5,369,181 | |
| -19,540,201 | |
| -19,850,404 | |
| -21,002,139 | |
| -13,346,033 | |
| 42,547 | |
| 5,750 | |
| -1,683 | |
| -23,980,608 | |
| -21,789,168 | |
| -23,713,168 | |
| -20,140,000 | |
| 6,571,000 | |
| -6,739,000 | |
| -5,479,000 | |
| -9,535,000 | |
| -6,227,000 | |
| -2,387,000 | |
| -2,128,000 | |
| -2,195,000 | |
| -8,745,000 | |
| -1,855,436 | |
| -2,024,000 |